Cytogenetic data for 4 MDS samples
. | . | %abnormal cells (abnormal/total nuclei or total colonies) . | . | . | . | . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient no. . | . | Initial sample* . | . | . | FACS-sorted human CD45/71+ cells from individual mice . | . | . | . | ||||||
. | FISH probe . | Total cells . | CFCs . | LTC-ICs . | Wk 3 . | Wk 5-7 . | Wk 8-12 . | Wk 15-23 . | ||||||
1 | 8 centromere | 64 (329/516) | 100† (10/10) | 100 (15/15) | 28 (60/212) | 29 (37/128) | 9 (51/566) | 2.7-1.6 (35/1309)-(12/772) | ||||||
8 | 5q31 | 100† (23/23) | 94 (17/18) | 95 (18/19) | — | — | — | 85 (128/150) | ||||||
9 | 8 centromere | 11 (56/500) | — | — | 3; 11 (2/63;207/1845) | 0.4; 9 (7, 18)‡ (10/2272; 119/1343) | — | — | ||||||
11 | 8 centromere | 8 (66/864) | 0 (0/40) | 0† (0/5) | 1.5 (14/957) | 1 (10/902) | — | 0.6 (3/538) |
. | . | %abnormal cells (abnormal/total nuclei or total colonies) . | . | . | . | . | . | . | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Patient no. . | . | Initial sample* . | . | . | FACS-sorted human CD45/71+ cells from individual mice . | . | . | . | ||||||
. | FISH probe . | Total cells . | CFCs . | LTC-ICs . | Wk 3 . | Wk 5-7 . | Wk 8-12 . | Wk 15-23 . | ||||||
1 | 8 centromere | 64 (329/516) | 100† (10/10) | 100 (15/15) | 28 (60/212) | 29 (37/128) | 9 (51/566) | 2.7-1.6 (35/1309)-(12/772) | ||||||
8 | 5q31 | 100† (23/23) | 94 (17/18) | 95 (18/19) | — | — | — | 85 (128/150) | ||||||
9 | 8 centromere | 11 (56/500) | — | — | 3; 11 (2/63;207/1845) | 0.4; 9 (7, 18)‡ (10/2272; 119/1343) | — | — | ||||||
11 | 8 centromere | 8 (66/864) | 0 (0/40) | 0† (0/5) | 1.5 (14/957) | 1 (10/902) | — | 0.6 (3/538) |